Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1

[1]  L. Garavelli,et al.  Patterns of Novel Alleles and Genotype/Phenotype Correlations Resulting from the Analysis of 108 Previously Undetected Mutations in Patients Affected by Neurofibromatosis Type I , 2017, International journal of molecular sciences.

[2]  S. Ulusal,et al.  Genetic Analyses of the NF1 Gene in Turkish Neurofibromatosis Type I Patients and Definition of three Novel Variants , 2017, Balkan journal of medical genetics : BJMG.

[3]  M. Leshno,et al.  Predicting neurofibromatosis type 1 risk among children with isolated café‐au‐lait macules , 2017, Journal of the American Academy of Dermatology.

[4]  Kimberly J. Johnson,et al.  Neurofibromatosis type 1 , 2017, Nature Reviews Disease Primers.

[5]  S. Banerjee,et al.  Novel phenotypes of NF1 patients from unrelated Chinese families with tibial pseudarthrosis and anemia , 2016, Oncotarget.

[6]  Ji Woon Park,et al.  Neurofibromatosis Type 1 Accompanied by Craniofacial Pain: Literature Review and Descriptive Case. , 2017, Journal of oral & facial pain and headache.

[7]  Á. Hernández-Martín,et al.  Neurofibromatosis tipo 1: más que manchas café con leche, efélides y neurofibromas. Parte I. Actualización sobre los criterios dermatológicos diagnósticos de la enfermedad , 2016 .

[8]  K. Rauen,et al.  Expansion of the RASopathies , 2016, Current Genetic Medicine Reports.

[9]  S. Perreault,et al.  Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature. , 2016, Pediatric neurology.

[10]  A. Duat‐Rodríguez,et al.  An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots, Freckling, and Neurofibromas. An Update. Part I. Dermatological Clinical Criteria Diagnostic of the Disease. , 2016, Actas dermo-sifiliograficas.

[11]  Yiping Shen,et al.  Diagnostic value of multiple café‐au‐lait macules for neurofibromatosis 1 in Chinese children , 2016, The Journal of dermatology.

[12]  M. Gómez,et al.  [Molecular diagnosis as a strategy for differential diagnosis and at early ages of neurofibromatosis type 1 (NF1)]. , 2015, Revista medica de Chile.

[13]  R. Ferner,et al.  Neurofibromatosis-related tumors: emerging biology and therapies , 2015, Current opinion in pediatrics.

[14]  D. Gutmann,et al.  Neurofibromatosis type 1: a multidisciplinary approach to care , 2014, The Lancet Neurology.

[15]  A. Bolčeková,et al.  Thirty‐Nine Novel Neurofibromatosis 1 (NF1) Gene Mutations Identified in Slovak Patients , 2013, Annals of human genetics.

[16]  Seon-Yong Jeong,et al.  Mutation spectrum of NF1 and clinical characteristics in 78 Korean patients with neurofibromatosis type 1. , 2013, Pediatric neurology.

[17]  Y. Zhang,et al.  A novel NF1 mutation in a Chinese patient with giant café-au-lait macule in neurofibromatosis type 1 associated with a malignant peripheral nerve sheath tumor and bone abnormality. , 2012, Genetics and molecular research : GMR.

[18]  D. Cooper,et al.  Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations? , 2012, Human Genomics.

[19]  D. Gutmann,et al.  Developmental Delays in Children With Neurofibromatosis Type 1 , 2012, Journal of child neurology.

[20]  E. Zackai,et al.  Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome. , 2009, JAMA.

[21]  K. Rauen,et al.  The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. , 2009, Current opinion in genetics & development.

[22]  G. Neri,et al.  A premature infant with Costello syndrome due to a rare G13C HRAS mutation , 2009, American journal of medical genetics. Part A.

[23]  B. Korf,et al.  The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. , 1997, JAMA.

[24]  Harold C. Sox,et al.  National Institutes of Health Consensus Development Conference Statement: Geriatric Assessment Methods for Clinical Decision‐making , 1988 .

[25]  Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. , 1988, Archives of neurology.